Evidence map›Paper›PMID 38553012›Full record

ArticleOpen heart2024

Oral anticoagulation therapy initiation in patients with atrial fibrillation in relation to world region of origin: a register-based nationwide study.

Juliane Frydenlund, Jan Brink Valentin, Marie Norredam, Lars Frost, Sam Riahi, Kristian Hay Kragholm, Henrik Bøggild, Gregory Y H Lip, Søren Paaske Johnsen

Abstract read
In one paragraph

Article in Open heart, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juliane FrydenlundDepartment of Clinical Medicine, Aalborg University, Gistrup, Denmark julianefrydenlund@rcsi.com.ORCID 0000-0003-0864-1577
Jan Brink ValentinDepartment of Clinical Medicine, Aalborg University, Gistrup, Denmark.
Marie NorredamSection of Health Services Research Copenhagen, Copenhagen, Denmark.
Lars FrostUniversity Clinic for Development of Innovative Patient Pathways, Silkeborg Regional Hospital, Silkeborg, Denmark.ORCID 0000-0001-9215-9796
Sam RiahiDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Kristian Hay KragholmDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0001-9629-8670
Henrik BøggildPublic Health and Epidemiology Department of Health Science and Technology, Aalborg University, Gistrup, Denmark.
Gregory Y H LipDepartment of Clinical Medicine, Aalborg University, Gistrup, Denmark.
Søren Paaske JohnsenDepartment of Clinical Medicine, Aalborg University, Gistrup, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) is the most common sustained arrhythmia and results in a high risk of stroke. The number of immigrants is increasing globally, but little is known about potential differences in AF care across migrant populations.

aimTo investigate if initiation of oral anticoagulation therapy (OAC) differs for patients with incident AF in relation to country of origin.

methodsA nationwide register-based study covering 1999-2017. AF was defined as a first-time diagnosis of AF and a high risk of stroke. Stroke risk was defined according to guidelines from the European Society of Cardiology (ESC). Poisson regression adjusted for sex, age, socioeconomic position and comorbidity was made to compute incidence rate ratios (IRR) for initiation of OAC.

resultsThe AF population included 254 586 individuals of Danish origin, 6673 of Western origin and 3757 of non-Western origin. Overall, OAC was initiated within -30/+90 days relative to the AF diagnosis in 50.3% of individuals of Danish origin initiated OAC, 49.6% of Western origin and 44.5% of non-Western origin. Immigrants from non-Western countries had significantly lower adjusted IRR of initiating OAC according to all ESC guidelines compared with patients of Danish origin. The adjusted IRRs ranged from 0.73 (95% CI: 0.66 to 0.80) following the launch of the 2010 ESC guideline to 0.89 (95% CI: 0.82 to 0.97) following the launch of the 2001 ESC guideline.

conclusionPatients with AF with a high risk of stroke of non-Western origin have persistently experienced a lower chance of initiating OAC compared with patients of Danish origin during the last decades.

Indexed as

Atrial FibrillationStrokeAnticoagulantsComorbidityHumansRisk FactorsAnticoagulantsAtrial FibrillationEpidemiologyPharmacology

Identifiers

PMID38553012
PMCPMC10982797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.